The teamX

Florian Vogl

Chief Medical Officer

Linkedin :

Florian brings to Cellestia a unique blend of drug development expertise and experience from clinical practice. Prior to joining Cellestia, he was Head of Clinical Development Europe at Rainier Therapeutics. Previously he held roles of increasing responsibility at Novartis Oncology and Amgen in Europe and the US. Before transitioning to the biopharmaceutical industry, Florian had a career as a physician scientist where he practiced medicine and led research projects.

“I am passionate about developing treatments that make a difference in the lives of patients and their families. With Cellestia’s innovative science we are bringing new treatments to patients with cancer or inflammatory conditions who have no other therapeutic options.”

Florian received his MD and a PhD in clinical pharmacology from the University of Munich; he completed a postdoctoral fellowship at the International Agency for Research on Cancer in Lyon.